Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
---|
07/03/2001 | US6254646 Oxidizing composition and uses for dyeing, permanently setting or bleaching keratin fibres |
06/28/2001 | WO2001046140A1 Ep4 receptor selective agonists in the treatment of osteoporosis |
06/28/2001 | WO2000078322A3 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
06/28/2001 | WO2000072855A3 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
06/28/2001 | WO2000057865A3 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
06/28/2001 | WO2000051545A3 Hair care compositions |
06/27/2001 | EP1110953A1 Quinazoline derivatives |
06/27/2001 | EP1110949A1 EP4 receptor selective agonists in the treatment of osteoporosis |
06/27/2001 | EP1109787A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
06/27/2001 | EP1109537A1 Immediate release tablet |
06/27/2001 | EP1109527A2 Cosmetic composition |
06/27/2001 | CN1301253A Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |
06/27/2001 | CN1301166A Steroidal saponins for treating alzheimer's disease |
06/27/2001 | CN1301165A Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
06/27/2001 | CN1301164A New treatment for nervous disorders |
06/27/2001 | CN1301160A Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal frailty |
06/27/2001 | CN1067550C Calcium receptor active molecules |
06/26/2001 | US6253104 Method of preparing pharmaceutical Moxa extract and apparatus for electrical moxibustion using the same extract |
06/26/2001 | US6251916 For therapy of pain |
06/26/2001 | US6251904 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
06/26/2001 | US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis |
06/26/2001 | US6251436 Drug preparations for treating sexual dysfunction |
06/26/2001 | US6251380 Extraction of plants with methanol, dichloromethane, ethyl acetate, mixing and drying then dilution |
06/26/2001 | US6251368 Aerosol drugs salmeterol, salbutamol, fluticasone propionate, beclomethasone dipropionate and physiologically acceptable salts |
06/26/2001 | US6251145 Enzyme of 2-electron oxidoreductase type in the presence of at least one donor for the said enzyme; cationic polymer |
06/22/2001 | CA2329678A1 Ep4 receptor selective agonists in the treatment of osteoporosis |
06/21/2001 | WO2001044291A2 Polynucleotid encoding the rg1 polypeptide |
06/21/2001 | WO2001044242A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases |
06/21/2001 | WO2001043709A1 Hair bleaching and colouring compositions having a ph greater than ph 10 comprising cholesterol |
06/21/2001 | US20010003851 Hair colorant composition containing phytantriol |
06/21/2001 | CA2394574A1 Dna encoding a novel rg1 polypeptide |
06/21/2001 | CA2394552A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamideinhibitors of cyclin dependent kinases |
06/20/2001 | EP1108417A2 Hair colorant composition |
06/20/2001 | EP1107746A2 Methods of using and compositions comprising dopamine reuptake inhibitors |
06/20/2001 | CN1300303A Enzyme inhibitors |
06/20/2001 | CN1300213A Gamma-contained aminobutyric acid derivatives solid compositions and preparation process thereof |
06/20/2001 | CN1300212A Novel fatty analogues for the treatment of obesity, hypertension and fatty liver |
06/20/2001 | CN1300211A Novel fatty analogues for the treatment of premary and secondary restenosis |
06/20/2001 | CN1299973A HCV-free-blood external preparing method |
06/20/2001 | CN1299643A Beauty method for making skin white |
06/19/2001 | US6248747 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
06/19/2001 | CA2191129C Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin |
06/14/2001 | WO2001042252A1 New aminopropylphosphinic acids |
06/14/2001 | WO2001042193A1 β2-ADRENERGIC RECEPTOR AGONISTS |
06/14/2001 | WO2001041766A1 The combination of a serotonin reuptake inhibitor and irindalone |
06/14/2001 | WO2001041701A2 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
06/14/2001 | US20010003749 Arylpiperazines having activity at the serotonin 1A receptor |
06/14/2001 | CA2393470A1 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
06/13/2001 | EP1105152A1 Tnf-derived peptides for use in treating oedema |
06/13/2001 | EP1105145A1 Method and pharmaceutical composition for reducing serum homocysteine concentration |
06/13/2001 | EP1105144A1 Composition and method for eliminating undigested fat and reducing cholesterol in the human body |
06/13/2001 | CN1299367A 2''-deoxy hygromycin derivatives |
06/13/2001 | CN1299365A Hygromycin A derivatives |
06/13/2001 | CN1299249A Reagent for tumor therapy and/or imaging |
06/13/2001 | CN1067075C Pyrrolo-gyrrolone used as neutrophil elastase inhibitor |
06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
06/12/2001 | US6245745 Bactericides and antiprotozoa agents |
06/12/2001 | CA2060384C A pharmaceutical composition containing an antibody recognizing the cdw52 antigen |
06/07/2001 | WO2001039784A1 Pancreatic stem cells and their use in transplantation |
06/07/2001 | WO2001039720A2 Dna polymerase inhibitors, mikanolide and dihydromikanolide |
06/07/2001 | CA2393056A1 New dna polymerase inhibitors, mikanolide and dihydromikanolide |
06/07/2001 | CA2392615A1 Pancreatic stem cells and their use in transplantation |
06/06/2001 | EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
06/06/2001 | EP1104289A2 New oral formulation for 5-ht4 agonists or antagonists |
06/06/2001 | CN1298294A Nicotine inhaler |
06/06/2001 | CN1066718C Substituted aryloxy-alkyl diamines and its producing process and use |
06/05/2001 | US6242606 Reacting a a,a-dimethylphenylacetic acid amide with a w-halo compound produces w'-halo-a-keto-a,a-dimethylphenylacetic acid amide and reacting it with a piperidine compound; 2-(4-(4-chloro-butyryl)-phenyl)-2-methy-propionic acid |
06/05/2001 | US6241988 Stable extract of hypericum perforatum L., a method for producing the same, and corresponding pharmaceutical preparations |
06/05/2001 | US6241976 With continuous phase containg water-immiscible liquid carrier and gel-forming structurant, disperse phase which is solution of antiperspirant active in water, optional solvent |
05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
05/31/2001 | WO2001038310A1 2-arylquinoline derivatives, preparation and therapeutic use thereof |
05/31/2001 | WO2001037848A1 Mixture of pomegranate seed oil and juice products |
05/31/2001 | WO2001037845A1 Treatment of heart rhythm disturbances with n6-substituted-5'-(n-substituted) carboxamidoadenosines |
05/31/2001 | WO2001037826A1 Npyy5 antagonists |
05/31/2001 | WO2001003683A3 Cardioactive composition comprising l-carnitine and its derivatives and crataegus extracts |
05/31/2001 | WO2000050072A3 Method for the purification, recovery, and sporulation of cysts and oocysts |
05/31/2001 | US20010002290 Comprising allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water; skin protectant |
05/31/2001 | US20010002260 Extracts of zanthoxylum bungeanum, and pharmaceutical and cosmetic formulations containing same |
05/31/2001 | CA2392369A1 Treatment of heart rhythm disturbances with n6-substituted-5'-(n-substituted) carboxamidoadenosines |
05/31/2001 | CA2392149A1 2-arylquinoline derivatives, preparation and therapeutic use thereof |
05/31/2001 | CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
05/31/2001 | CA2389537A1 Mixture of pomegranate seed oil and juice products |
05/30/2001 | EP1103251A1 Use of 1,1-dioxoperhydro-1,2,4-thiadiazines |
05/30/2001 | EP1102747A1 Crystalline forms of osanetant |
05/30/2001 | EP1102584A2 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
05/30/2001 | EP0859582B1 Strengthening agent |
05/30/2001 | CN1297478A Compositions comprising viruses and methods for concentrating virus preparations |
05/30/2001 | CN1297449A Novel 2-heterocyclically substd. dihydropyrimidines |
05/30/2001 | CN1297356A Matrix protein compositions for wound healing |
05/30/2001 | CN1297351A Intermittent claudication therapeutic drugs comprising pyrroloazepines |
05/29/2001 | US6239147 To treat cns, gastrointestinal and other disorders. substance p antagonists having improved activity and fewer side effects, treatment of emesis induced by antineoplastic agents, isochroman ring |
05/29/2001 | US6239135 Arylpiperazines having activity at the serotonin 1A receptor |
05/29/2001 | US6239113 Topical treatment or prevention of ocular infections |
05/29/2001 | US6238664 Process for stabilizing proteins |
05/29/2001 | US6238647 Anticholinergic medicament which is selected from the group consisting of ipratropium, atropine, oxitropium and salts thereof |
05/29/2001 | CA2325778A1 Use of 1,1-dioxoperhydro-1,2,4-thiadiazines |
05/25/2001 | WO2001036001A2 Interferon gamma conjugates |
05/25/2001 | CA2390292A1 Interferon gamma conjugates |
05/24/2001 | US20010001659 Inorganic sunscreen agent such as titanium dioxide, an anioic emulsifier, a carrier oil and at least one emollient; high sun protection factor without whitening effects |
05/23/2001 | CN1296488A Bicycle hydroxamic acid derivatives |